168 related articles for article (PubMed ID: 22688980)
1. The normal chain length distribution of the O antigen is required for the interaction of Shigella flexneri 2a with polarized Caco-2 cells.
Hoare A; Bravo D; Martinić M; Valvano MA; Contreras I; Álvarez SA
Biol Res; 2012; 45(1):21-6. PubMed ID: 22688980
[TBL] [Abstract][Full Text] [Related]
2. Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence.
Morona R; Daniels C; Van Den Bosch L
Microbiology (Reading); 2003 Apr; 149(Pt 4):925-939. PubMed ID: 12686635
[TBL] [Abstract][Full Text] [Related]
3. Influence of Shigella flexneri 2a O Antigen Acetylation on Its Bacteriophage Sf6 Receptor Activity and Bacterial Interaction with Human Cells.
Teh MY; Furevi A; Widmalm G; Morona R
J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32989087
[No Abstract] [Full Text] [Related]
4. O-antigen modal chain length in Shigella flexneri 2a is growth-regulated through RfaH-mediated transcriptional control of the wzy gene.
Carter JA; Blondel CJ; Zaldívar M; Álvarez SA; Marolda CL; Valvano MA; Contreras I
Microbiology (Reading); 2007 Oct; 153(Pt 10):3499-3507. PubMed ID: 17906147
[TBL] [Abstract][Full Text] [Related]
5. The cellular level of O-antigen polymerase Wzy determines chain length regulation by WzzB and WzzpHS-2 in Shigella flexneri 2a.
Carter JA; Jiménez JC; Zaldívar M; Álvarez SA; Marolda CL; Valvano MA; Contreras I
Microbiology (Reading); 2009 Oct; 155(Pt 10):3260-3269. PubMed ID: 19556292
[TBL] [Abstract][Full Text] [Related]
6. Optimization of virulence functions through glucosylation of Shigella LPS.
West NP; Sansonetti P; Mounier J; Exley RM; Parsot C; Guadagnini S; Prévost MC; Prochnicka-Chalufour A; Delepierre M; Tanguy M; Tang CM
Science; 2005 Feb; 307(5713):1313-7. PubMed ID: 15731456
[TBL] [Abstract][Full Text] [Related]
7. Relationship between O-antigen chain length and resistance to colicin E2 in Shigella flexneri.
Tran ENH; Papadopoulos M; Morona R
Microbiology (Reading); 2014 Mar; 160(Pt 3):589-601. PubMed ID: 24425769
[TBL] [Abstract][Full Text] [Related]
8. Coiled-coil regions play a role in the function of the Shigella flexneri O-antigen chain length regulator WzzpHS2.
Purins L; Van Den Bosch L; Richardson V; Morona R
Microbiology (Reading); 2008 Apr; 154(Pt 4):1104-1116. PubMed ID: 18375803
[TBL] [Abstract][Full Text] [Related]
9. Multicopy icsA is able to suppress the virulence defect caused by the wzz(SF) mutation in Shigella flexneri.
Morona R; Van Den Bosch L
FEMS Microbiol Lett; 2003 Apr; 221(2):213-9. PubMed ID: 12725929
[TBL] [Abstract][Full Text] [Related]
10. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
Jennison AV; Roberts F; Verma NK
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide O antigen chains mask IcsA (VirG) in Shigella flexneri.
Morona R; Van Den Bosch L
FEMS Microbiol Lett; 2003 Apr; 221(2):173-80. PubMed ID: 12725923
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the lipopolysaccharide to resistance of Shigella flexneri 2a to extreme acidity.
Martinić M; Hoare A; Contreras I; Alvarez SA
PLoS One; 2011; 6(10):e25557. PubMed ID: 21984920
[TBL] [Abstract][Full Text] [Related]
13. Effect of O side-chain length and composition on the virulence of Shigella flexneri 2a.
Sandlin RC; Goldberg MB; Maurelli AT
Mol Microbiol; 1996 Oct; 22(1):63-73. PubMed ID: 8899709
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
16. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Shigella flexneri Wzy Domain Modulating Wzz
Ascari A; Tran ENH; Eijkelkamp BA; Morona R
J Bacteriol; 2022 Sep; 204(9):e0022422. PubMed ID: 35980183
[TBL] [Abstract][Full Text] [Related]
18. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine.
Phalipon A; Costachel C; Grandjean C; Thuizat A; Guerreiro C; Tanguy M; Nato F; Vulliez-Le Normand B; Bélot F; Wright K; Marcel-Peyre V; Sansonetti PJ; Mulard LA
J Immunol; 2006 Feb; 176(3):1686-94. PubMed ID: 16424198
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz.
Murray GL; Attridge SR; Morona R
Mol Microbiol; 2003 Mar; 47(5):1395-406. PubMed ID: 12603743
[TBL] [Abstract][Full Text] [Related]
20. Regulation of O-antigen chain length is required for Shigella flexneri virulence.
Van den Bosch L; Manning PA; Morona R
Mol Microbiol; 1997 Feb; 23(4):765-75. PubMed ID: 9157247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
